drugset / Trial / NCT02169713
Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects
RandomizedCrossoverDouble-blindBasic science
Summary
The purpose of this study is to evaluate the effect of solifenacin and mirabegron on the concentrations of tamsulosin HCl after combined dosing. This study will also evaluate the safety and tolerability of the combined administration of solifenacin, mirabegron and tamsulosin HCl.
Timeline
- Start
- 2014-05
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirabegron | Other / unclassified | — | Oral |
| Subject | Solifenacin | Small molecule | — | Oral |
| Subject | Tamsulosin | Other / unclassified | — | Oral |
Indications
No indication recorded.